is a boutique law firm handling complex and class action litigation, including shareholder derivative litigation, securities class actions, data breach and consumer class actions.

Current Securities Class Action Cases

Federman & Sherwood regularly posts press releases about new class action securities cases, which includes the class period and deadlines for appointment of lead plaintiffs.  Please review any of the case listings  below, and if you bought a security during the class period, we invite you to return an investor certification to our office. Our link to an investor certification for any of the cases can be found below each respective press release on that company.  Once completed, please return to our office by email to or fax to (405) 239-2112. 

Current Cases

Cardiovascular Systems, Inc. [NASDAQ: CSII]

Federman & Sherwood Announces the Filing of a Securities Class Action Lawsuit against Cardiovascular Systems, Inc.


Oklahoma City, OK (February 16, 2016) – On February 12, 2016, a securities class action lawsuit was filed in the United States District Court for the Central District of California against Cardiovascular Systems, Inc. (NASDAQ: CSII).  The complaint alleges violations of federal securities laws, Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5, including allegations of issuing a series of material or false misrepresentations to the market which had the effect of artificially inflating the market price during the Class Period, which is September 12, 2011 through January 21, 2016.  More specifically, this litigation was filed because throughout the Class Period the Company issued false and misleading statements to investors and/or failed to disclose that: (1) Cardiovascular Systems distributed illegal kickbacks to health care providers; (2) Cardiovascular Systems engaged in the off-label promotion of its medical devices; and (3) Cardiovascular Systems violated FDA laws and regulations in connection with its medical devices.

On January 21, 2016, post-market, the Company disclosed that the expected revenue from its 2016 fiscal second quarter to be 4% lower than the same period in the previous year and 3% below the guidance range, due to the continued effects of the sales force transition.  On this news, Cardiovascular Systems stock fell $3.72 per share to close at $8.74 per share on January 22, 2016.

Plaintiff seeks to recover damages on behalf of all Cardiovascular Systems, Inc. shareholders who purchased common stock during the Class Period and are therefore a member of the Class as described above.  You may move the Court no later than Tuesday, April 12, 2016 to serve as a lead plaintiff for the entire Class.  However, in order to do so, you must meet certain legal requirements pursuant to the Private Securities Litigation Reform Act of 1995.

To join this class action, click here to obtain an investor certification.  Once complete, please email this form to, fax to us at (405) 239-2112 or send by regular mail to Federman & Sherwood, 10205 North Pennsylvania Avenue, Oklahoma City, OK 73120, ATTN:  Robin.

Copyright © 2018 Federman & Sherwood. All Rights Reserved.